Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis in Myocardial Infarction [TIMI] trials)

被引:22
作者
Llevadot, J
Giugliano, RP
McCabe, CH
Cannon, CP
Antman, EM
Murphy, S
Gibson, CM
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA
[2] Univ Calif San Francisco, Dept Med, Div Cardiovasc, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S0002-9149(00)00786-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was undertaken to characterize residual stenosis after thrombolytic administration and to evaluate clinical and angiographic features and early outcomes of patients with mild residual obstruction after thrombolytic administration. Patients who underwent angiography at 90 minutes after thrombolytic: administration in the Thrombolysis In Myocardial Infarction 4, 10A, 10B, and 14 trials were divided into 3 groups according to the degree of residual stenosis measured by quantitative coronary angiography: patients with a patent culprit artery with <50% stenosis, patients with patent arteries and residual stenosis greater than or equal to 50%, and patients with occluded arteries. Only 8.9% of the patients (188 of 2,119) had an infarct-related artery luminal diameter stenosis of <50% 90 minutes after thrombolysis. Compared with patients with patent arteries and greater than or equal to 50% stenosis, patients with mild residual obstruction were younger (56.8 vs 58.6 years; p = 0.03), had fewer prior myocardial infarctions (6.9% vs 13.3%; p = 0.01), fewer eccentric (19.8% vs 42.1%; p <0.0001), ulcerated (7.5% vs 13.2%; p = 0.03), and collateralized (6.6% vs 13.2%, p = 0.01) lesions, but ct greater thrombus burden (29.7% vs 18.3%, p = 0.0002). Among patients with patent arteries, a residual stenosis of <50% was associated with a significantly lower composite of in-hospital death, myocardial infarction, and congestive heart failure (2.8% vs 7.1%, p = 0.03). Thus, a minority of patients have a mild residual obstruction at 90 minutes after thrombolytic administration. These patients have less complex lesions with greater thrombus burdens and better clinical outcomes. (C) 2000 by Excerpta Medica, Inc.
引用
收藏
页码:1409 / 1413
页数:5
相关论文
共 30 条
[1]   5-YEAR ANGIOGRAPHIC FOLLOW-UP OF FACTORS ASSOCIATED WITH PROGRESSION OF CORONARY-ARTERY DISEASE IN THE CORONARY-ARTERY SURGERY STUDY (CASS) [J].
ALDERMAN, EL ;
CORLEY, SD ;
FISHER, LD ;
CHAITMAN, BR ;
FAXON, DP ;
FOSTER, ED ;
KILLIP, T ;
SOSA, JA ;
BOURASSA, MG ;
DOYLE, JT ;
MCKNEALLY, MF ;
MCILDUFF, JB ;
ODABASHIAN, H ;
OLDER, TM ;
RYAN, T ;
WEXLER, L ;
BARNER, HB ;
TYRAS, DH ;
CIPRIANO, PR ;
STINSON, EB ;
KENNEDY, JW ;
SOLOMON, R ;
PASSAMANI, ER ;
BERGER, RL ;
WEINER, D ;
GOULET, C ;
LESPERANCE, J ;
GRONDIN, CH ;
CASTONGUAY, Y ;
KAISER, G ;
MUDD, JG ;
WIENS, RD ;
CODD, JE ;
WILLMAN, VL ;
KOCH, FH ;
SILVERMAN, J ;
DAVIS, K ;
GILLESPIE, MJ ;
KRONMAL, R ;
SOPKO, G ;
ROBERTSON, T ;
FROMMER, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) :1141-1154
[2]   ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE AND THE DEVELOPMENT OF MYOCARDIAL-INFARCTION [J].
AMBROSE, JA ;
TANNENBAUM, MA ;
ALEXOPOULOS, D ;
HJEMDAHLMONSEN, CE ;
LEAVY, J ;
WEISS, M ;
BORRICO, S ;
GORLIN, R ;
FUSTER, V .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (01) :56-62
[3]  
[Anonymous], 1988, LANCET, V2, P349
[4]  
[Anonymous], 1988, BRIT MED J, V296, P320
[5]   Abciximab facilitates the rate and extent of thrombolysis - Results of the thrombolysis in myocardial infarction (TIMI) 14 trial [J].
Antman, EM ;
Giugliano, RP ;
Gibson, CM ;
McCabe, CH ;
Coussement, P ;
Kleiman, NS ;
Vahanian, A ;
Adgey, AAJ ;
Menown, I ;
Rupprecht, HJ ;
Van der Wieken, R ;
Ducas, J ;
Scherer, J ;
Anderson, K ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 1999, 99 (21) :2720-2732
[6]   TNK tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction - Results of the TIMI 10B trial [J].
Cannon, CP ;
Gibson, CM ;
McCabe, CH ;
Adgey, AAJ ;
Schweiger, MJ ;
Sequeira, RF ;
Grollier, G ;
Giugliano, RP ;
Frey, M ;
Mueller, HS ;
Steingart, RM ;
Weaver, WD ;
Van de Werf, F ;
Braunwald, E .
CIRCULATION, 1998, 98 (25) :2805-2814
[7]   COMPARISON OF FRONT-LOADED RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, ANISTREPLASE AND COMBINATION THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) 4 TRIAL [J].
CANNON, CP ;
MCCABE, CH ;
DIVER, DJ ;
HERSON, S ;
GREENE, RM ;
SHAH, PK ;
SEQUEIRA, RF ;
LEYA, F ;
KIRSHENBAUM, JM ;
MAGORIEN, RD ;
PALMERI, ST ;
DAVIS, V ;
GIBSON, CM ;
POOLE, WK ;
BRAUNWALD, E ;
PULEO, P ;
ABENDSCHEIN, D ;
LOSCALZO, J ;
CHAITMAN, BR ;
ZARET, BL ;
DANGOISSE, V ;
FLAKER, GC ;
GARRISON, TW ;
SCHWEIGER, MJ ;
MAHRER, PR ;
SHOOK, TL ;
ANDERSON, JL ;
PALISAITIS, D ;
COHN, PF ;
LARAMEE, LA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (07) :1602-1610
[8]  
Cannon CP, 1997, CIRCULATION, V95, P351
[9]   DETERMINANTS OF COLLATERAL FILLING OBSERVED DURING SUDDEN CONTROLLED CORONARY-ARTERY OCCLUSION IN HUMAN-SUBJECTS [J].
COHEN, M ;
SHERMAN, W ;
RENTROP, KP ;
GORLIN, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (02) :297-303
[10]   PREVIOUS ASPIRIN USE MAY ATTENUATE THE SEVERITY OF THE MANIFESTATION OF ACUTE ISCHEMIC SYNDROMES [J].
GARCIADORADO, D ;
THEROUX, P ;
TORNOS, P ;
SAMBOLA, A ;
OLIVERAS, J ;
SANTOS, M ;
SOLER, JS .
CIRCULATION, 1995, 92 (07) :1743-1748